Company / Interest Expense per Share
GT Biopharma, Inc. Interest Expense per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-$0.52
FY2020
5-year range
-$0.52 / $62.90
FY2016-FY2020
Trend
-100.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 8 years, ranging from $-0.52 in FY2020 to $62.90 in FY2017.
Based on SEC 10-K filings.
-0.52 in FY2020.
Improved from $7.10 to $-0.52 over the past 4 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, interest expense per share decreased 100.8% year-over-year.
- Peak interest expense per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$0.52 | -100.8% |
| FY2017 | $62.90 | +785.9% |
| FY2016 | $7.10 | +226.5% |
| FY2015 | $2.17 | +104086.1% |
| FY2014 | $0.00 | -36.8% |
| FY2013 | $0.00 | +59.9% |
| FY2012 | $0.00 | -39.8% |
| FY2011 | $0.00 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026